PCSK9 Inhibitor on ACS Patients With Multivessel Disease and Relatively Low LDL-C Level in Chinese Population
Clinical trial NCT05043740 · UNKNOWN
Trial details
- NCT number
- NCT05043740
- Sponsor
- Second Xiangya Hospital of Central South University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2023-10-01
- Enrollment
- 1360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.